My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Item 27 - Appeal Application Nos. 2020-03 and 2020-04 - Central Pointe Mixed-Use Development
Clerk
>
Agenda Packets / Staff Reports
>
City Council (2004 - Present)
>
2021
>
01/19/2021 Regular
>
Item 27 - Appeal Application Nos. 2020-03 and 2020-04 - Central Pointe Mixed-Use Development
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/10/2024 2:34:56 PM
Creation date
8/22/2023 9:23:52 AM
Metadata
Fields
Template:
City Clerk
Doc Type
Agenda Packet
Agency
Clerk of the Council
Item #
27
Date
1/19/2021
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
694
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Because these residences will be constructed with CARB Phase 2 Formaldehyde ATCM <br />materials, and be ventilated with the minimum code required amount of outdoor air, the <br />indoor residential formaldehyde concentrations are likely similar to those concentrations <br />observed in residences built with CARB Phase 2 Formaldehyde ATCM materials, which <br />is a median of 24.1 µg/m3 (Singer et. al., 2020) <br />Assuming that the residential occupants inhale 20 m3 of air per day, the average 70-year <br />lifetime formaldehyde daily dose is 482 µg/day for continuous exposure in the <br />residences. This exposure represents a cancer risk of 120 per million, which is more than <br />12 times the CEQA cancer risk of 10 per million. For occupants that do not have <br />continuous exposure, the cancer risk will be proportionally less but still substantially over <br />the CEQA cancer risk of 10 per million (e.g. for 12/hour/day occupancy, more than 6 <br />times the CEQA cancer risk of 10 per million). <br />Appendix A, Indoor Formaldehyde Concentrations and the CARB Formaldehyde ATOM, <br />provides analyses that show utilization of CARB Phase 2 Formaldehyde ATCM materials <br />will not ensure acceptable cancer risks with respect to formaldehyde emissions from <br />composite wood products. <br />Even composite wood products manufactured with CARB certified ultra low emitting <br />formaldehyde (ULEF) resins do not insure that the indoor air will have concentrations of <br />formaldehyde the meet the OEHHA cancer risks that substantially exceed 10 per million. <br />The permissible emission rates for ULEF composite wood products are only 11-15% <br />lower than the CARB Phase 2 emission rates. Only use of composite wood products made <br />with no -added formaldehyde resins (NAF), such as resins made from soy, polyvinyl <br />acetate, or methylene diisocyanate can insure that the OEHHA cancer risk of 10 per <br />million is met. <br />The following describes a method that should be used, prior to construction in the <br />environmental review under CEQA, for determining whether the indoor concentrations <br />resulting from the formaldehyde emissions of specific building materials/furnishings <br />selected exceed cancer and non -cancer guidelines. Such a design analyses can be used to <br />5of19 <br />
The URL can be used to link to this page
Your browser does not support the video tag.